Literature DB >> 19332692

A mechanism for low penetrance in an ALS family with a novel SOD1 deletion.

L Zinman1, H N Liu, C Sato, Y Wakutani, A F Marvelle, D Moreno, K E Morrison, K L Mohlke, J Bilbao, J Robertson, E Rogaeva.   

Abstract

BACKGROUND: About 20% of familial amyotrophic lateral sclerosis (ALS) is caused by mutations in SOD1 and is typically transmitted as an autosomal dominant trait. However, due to reduced mutation penetrance, the disease may present in a recessive or sporadic manner.
OBJECTIVE: To determine the factors responsible for the low penetrance of the SOD1 mutation.
METHODS: Twelve members of a Canadian ALS family of Filipino origin were recruited for the study. SOD1 was sequenced in the proband. SOD1 expression was assessed by real-time-PCR and immunoblotting.
RESULTS: The proband was a homozygous carrier of a novel 6 bp deletion in exon 2 (DeltaG27/P28), the pathologic significance of which was confirmed by immunohistochemistry. Eight living family members are heterozygotes and remain unaffected at ages ranging between 48 and 85 years. Haplotype analysis showed that the deletion is a single founder mutation likely common in the Cagayan province (Philippines). The low penetrance of the mutation is explained by the fact that it enhances the naturally occurring alternative splicing of exon 2 of the SOD1 mRNA, leading to reduced transcription of the mutant allele. Indeed, Western blot analysis demonstrated the low level of SOD1 protein in carriers of the DeltaG27/P28 compared to wild-type individuals or a carrier of the A4V SOD1 mutation.
CONCLUSION: The enhanced splicing of exon 2 acts as a natural knock-down of the mutant SOD1 allele in the Filipino amyotrophic lateral sclerosis (ALS) family. There is a need for careful investigation of splicing isoforms of SOD1 and other ALS genes as factors influencing the severity of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332692      PMCID: PMC2680064          DOI: 10.1212/01.wnl.0000345363.65799.35

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.

Authors:  D W Cleveland; J D Rothstein
Journal:  Nat Rev Neurosci       Date:  2001-11       Impact factor: 34.870

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

4.  D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype.

Authors:  Matthew J Parton; Wendy Broom; Peter M Andersen; Ammar Al-Chalabi; P Nigel Leigh; John F Powell; Christopher E Shaw
Journal:  Hum Mutat       Date:  2002-12       Impact factor: 4.878

5.  A catalogue of splice junction sequences.

Authors:  S M Mount
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

6.  Aberrant splicing of human Cu/Zn superoxide dismutase (SOD1) RNA transcripts.

Authors:  A Kawata; S Kato; T Shimizu; H Hayashi; S Hirai; H Misawa; R Takahashi
Journal:  Neuroreport       Date:  2000-08-21       Impact factor: 1.837

7.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

8.  Alternative splicing in disease and therapy.

Authors:  Mariano A Garcia-Blanco; Andrew P Baraniak; Erika L Lasda
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

9.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

10.  Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach.

Authors:  Han-Xiang Deng; Deng Han-Xiang; Hujun Jiang; Jiang Hujun; Ronggen Fu; Fu Ronggen; Hong Zhai; Zhai Hong; Yong Shi; Shi Yong; Erdong Liu; Liu Erdong; Makito Hirano; Hirano Makito; Mauro C Dal Canto; C Dal Canto Mauro; Teepu Siddique; Siddique Teepu
Journal:  Hum Mol Genet       Date:  2008-04-18       Impact factor: 6.150

View more
  12 in total

1.  A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.

Authors:  Maria Grazia Biferi; Mathilde Cohen-Tannoudji; Ambra Cappelletto; Benoit Giroux; Marianne Roda; Stéphanie Astord; Thibaut Marais; Corinne Bos; Thomas Voit; Arnaud Ferry; Martine Barkats
Journal:  Mol Ther       Date:  2017-06-26       Impact factor: 11.454

Review 2.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 3.  Genetics of Amyotrophic Lateral Sclerosis.

Authors:  Mehdi Ghasemi; Robert H Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 4.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

Review 5.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms.

Authors:  Patrick A Dion; Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2009-10-13       Impact factor: 53.242

6.  SOD1 Transcriptional and Posttranscriptional Regulation and Its Potential Implications in ALS.

Authors:  Pamela Milani; Stella Gagliardi; Emanuela Cova; Cristina Cereda
Journal:  Neurol Res Int       Date:  2011-04-17

Review 7.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

8.  Ligand binding and aggregation of pathogenic SOD1.

Authors:  Gareth S A Wright; Svetlana V Antonyuk; Neil M Kershaw; Richard W Strange; S Samar Hasnain
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  Is SOD1 loss of function involved in amyotrophic lateral sclerosis?

Authors:  Rachele A Saccon; Rosie K A Bunton-Stasyshyn; Elizabeth M C Fisher; Pietro Fratta
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

10.  Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.

Authors:  Hung-Jin Huang; Tung-Ti Chang; Hsin-Yi Chen; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.